Back to DNLI

Denali Therapeutics Inc. 8-K

Accession 0001714899-22-000105

Filing information

CIK
0001714899
Report date
2022-07-04
Filing date
2022-07-05
Form
8-K
Primary document
dnli-20220704.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.